Chronic Obstructive Pulmonary Disease and Inhaled Treatment Effects on Mortality in Patients with Lung Cancer

医学 慢性阻塞性肺病 肺癌 重症监护医学 内科学 肿瘤科
作者
Jin‐Woo Lee,Jiyu Sun,Hyun Woo Lee
出处
期刊:Annals of the American Thoracic Society [American Thoracic Society]
卷期号:22 (11): 1764-1773
标识
DOI:10.1513/annalsats.202409-990oc
摘要

Rationale: In patients with lung cancer, the impact of chronic obstructive pulmonary disease (COPD) diagnosis and subsequent management on mortality remains uncertain, because evidence supporting the efficacy of inhaled therapies in improving clinical outcomes in this population is limited. Objectives: This aim of this study was to assess whether COPD worsens outcomes in patients with lung cancer and to investigate whether inhaled treatments for COPD can improve these outcomes. Methods: This retrospective cohort study used the Korea Central Cancer Registry database from 2012 to 2019. Patients with lung cancer aged 40 years and older with health screening records were included. Patients were classified into COPD and non-COPD groups, and within the COPD group, they were further classified on the basis of inhaled therapy status. The primary outcome was all-cause mortality, and secondary outcomes included healthcare resource use. Subgroup analyses were conducted on the basis of lung cancer stage, histologic subtypes, and treatment modalities. Results: Among 113,071 patients with lung cancer, 38,145 (33.7%) had COPD. COPD was associated with higher all-cause mortality (adjusted hazard ratio, 1.327; 95% confidence interval, 1.305-1.350; P < 0.001), increased use of steroids and antibiotics, higher rates of hospital admissions, and more frequent emergency department visits. Patients with COPD receiving inhaled treatment had lower mortality rates at the 3-month landmark (adjusted hazard ratio, 0.934; 95% confidence interval, 0.895-0.975; P = 0.002). Notably, the dual bronchodilator combination (long-acting β-agonist/long-acting muscarinic antagonist) was associated with a significant mortality reduction, as observed across multiple landmark time points. Conclusions: COPD is linked to worse clinical outcomes in patients with lung cancer. Among the inhaled treatments, the long-acting β-agonist/long-acting muscarinic antagonist dual therapy showed a beneficial effect on mortality, whereas adding inhaled corticosteroids as part of triple therapy did not provide an additional survival benefit. This study suggests the importance of early COPD detection and timely initiation of inhaled therapy in patients with lung cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
大模型的应助被qianli采纳,获得10
1秒前
wx发布了新的文献求助20
1秒前
小芋完成签到,获得积分10
1秒前
Owen的应助被雪中漫步采纳,获得10
1秒前
玄魁完成签到,获得积分10
2秒前
啦啦啦完成签到,获得积分10
2秒前
喀纳斯发布了新的文献求助10
2秒前
my123完成签到,获得积分10
2秒前
HH发布了新的文献求助10
3秒前
细心珊完成签到,获得积分10
4秒前
4秒前
5秒前
烟花的应助被诺一44采纳,获得200
5秒前
DUMMY4869发布了新的文献求助10
5秒前
lilili发布了新的文献求助10
6秒前
东海派大星完成签到,获得积分10
6秒前
Menand完成签到,获得积分10
8秒前
春意盎然发布了新的文献求助10
8秒前
执着鞋子发布了新的文献求助10
8秒前
piaoxinglin完成签到,获得积分10
8秒前
梦欢完成签到,获得积分10
8秒前
传奇3的应助被坦率的夜玉采纳,获得10
8秒前
8秒前
8秒前
halo发布了新的文献求助10
9秒前
Ccomic完成签到,获得积分10
9秒前
李珂完成签到,获得积分10
11秒前
科研通AI65的应助被神奇蜥蜴采纳,获得10
11秒前
11秒前
123完成签到,获得积分10
12秒前
lx发布了新的文献求助20
12秒前
科研菜鸟完成签到,获得积分10
12秒前
wentong完成签到,获得积分10
12秒前
苹果熊猫完成签到,获得积分10
12秒前
12秒前
孔wj完成签到,获得积分10
12秒前
zz完成签到,获得积分10
13秒前
123完成签到,获得积分10
13秒前
细腻的香寒完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190556
求助须知:如何正确求助?哪些是违规求助? 9577718
关于积分的说明 21854300
捐赠科研通 7789692
什么是DOI,文献DOI怎么找? 3436425
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483090